Back to Search Start Over

GLA supplementation regulates PHD2 mediated hypoxia and mitochondrial apoptosis in DMBA induced mammary gland carcinoma.

Authors :
Roy S
Singh M
Rawat A
Devi U
Gautam S
Yadav RK
Rawat JK
Ansari MN
Saeedan AS
Kumar D
Kaithwas G
Source :
The international journal of biochemistry & cell biology [Int J Biochem Cell Biol] 2018 Mar; Vol. 96, pp. 51-62. Date of Electronic Publication: 2018 Feb 02.
Publication Year :
2018

Abstract

The aim of the present study is to evaluate the effect of gamma linolenic acid (GLA) on mitochondrial mediated death apoptosis, hypoxic microenvironment and cholinergic anti-inflammatory pathway against 7, 12-dimethylbenz (a) anthracene (DMBA) induced mammary gland carcinoma. The effects of GLA were evaluated morphologically and biochemically against DMBA induced mammary gland carcinoma. The metabolic study was done for evaluation of biomarkers using <superscript>1</superscript> H NMR. The present study was also verified through immunoblotting and qRT-PCR studies for the evaluation of various pathways. GLA treatment has a delineate implementation upon morphology of the tissues when evaluated through carmine staining, hematoxyline and eosin staining and scanning electron microscopy. GLA also demarked a commendatory proclamation of the fifteen key serum metabolites analogous with amino acid metabolism and fatty acid metabolism when recognized through <superscript>1</superscript> H NMR studies. The immunoblotting and qRT-PCR studies accomplished that GLA mediated mitochondrial death apoptosis, curtail hypoxic microenvironment along with hindrance of de novo fatty acid synthesis and also mediate the cholinergic anti-inflammatory pathway to proclaim its anticancer effects.<br /> (Copyright © 2018 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1878-5875
Volume :
96
Database :
MEDLINE
Journal :
The international journal of biochemistry & cell biology
Publication Type :
Academic Journal
Accession number :
29355756
Full Text :
https://doi.org/10.1016/j.biocel.2018.01.011